{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:28:21Z","timestamp":1783434501563,"version":"3.54.6"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>The prognosis of prostate cancers exhibiting extraprostatic extension [other than bladder or seminal vesicle invasion (EPE)] and\/or microscopic bladder neck invasion (mBNI) is variable, and further risk stratification is required. We herein assessed radical prostatectomy findings and long-term oncologic outcomes in consecutive 957 patients with pT3a disease. The patient cohort was divided into 4 groups, focal EPE (F-EPE) only (n=177; 18.5%), nonfocal\/established (E-EPE) only (n=634; 66.2%), mBNI only (n=51; 5.3%). The rate of positive surgical margin and estimated volume of tumor were significantly higher in patients with both EPE and mBNI than in those with either. In addition, compared with F-EPE or mBNI only, E-EPE only was significantly associated with higher Grade Group, lymph node metastasis, and larger tumor volume. Kaplan-Meier analysis revealed a comparable prognosis after prostatectomy between those showing F-EPE only versus mBNI only (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.986), and these 2 cohorts were combined for further analysis. Then, patients showing E-EPE only had a significantly higher or lower risk of progression compared with those showing F-EPE or mBNI only (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) or both EPE and mBNI (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), respectively. These significant differences in progression-free survival were also seen in subgroups, including those with or without undergoing adjuvant therapy before recurrence and those showing no lymph node metastasis. In multivariate analysis, F-EPE or mBNI only (hazard ratio=0.524, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.003) or both EPE and mBNI (hazard ratio=1.465, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.039) (vs. E-EPE only) showed significance for progression. Based on these findings, we propose a novel pT3a subclassification, pT3a1 (F-EPE or mBNI alone), pT3a2 (E-EPE alone), and pT3a3 (both EPE and mBNI).<\/jats:p>","DOI":"10.1097\/pas.0000000000001939","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T22:00:05Z","timestamp":1659996005000},"page":"1682-1687","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Clinical Significance of Either Extraprostatic Extension or Microscopic Bladder Neck Invasion Alone Versus Both in Men With pT3a Prostate Cancer Undergoing Radical Prostatectomy"],"prefix":"10.1097","volume":"46","author":[{"given":"Yuki","family":"Teramoto","sequence":"first","affiliation":[{"name":"Department of Pathology & Laboratory Medicine"},{"name":"James P. Wilmot Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Numbereye","family":"Numbere","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine"},{"name":"James P. Wilmot Cancer Institute"},{"name":"Department of Urology; University of Rochester Medical Center, Rochester, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,2]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistic, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistic 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/bju.14237","article-title":"Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer","volume":"122","author":"Lancee","year":"2018","journal-title":"BJU Int"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euf.2019.06.004","article-title":"Biochemical recurrence in prostate cancer: the European Association of Urology prostate cancer guidelines panel recommendations","volume":"6","author":"Van den Broeck","year":"2020","journal-title":"Eur Urol Focus"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1464-410X.2008.08096.x","article-title":"Prognostic significance of microscopic bladder neck invasion in prostate cancer","volume":"103","author":"Rodr\u00edguez-Covarrubias","year":"2008","journal-title":"BJU Int"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/modpathol.2010.158","article-title":"International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens. Working Group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease","volume":"24","author":"Magi-Galluzzi","year":"2011","journal-title":"Mod Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.juro.2013.06.050","article-title":"Extraprostatic extension into periprostatic fat is a more important determinant of prostate cancer recurrence than an invasive phenotype","volume":"190","author":"Kapoor","year":"2013","journal-title":"J Urol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.urology.2014.08.025","article-title":"Extent of extraprostatic extension independently influences biochemical recurrence-free survival: Evidence for further pT3 subclassification","volume":"85","author":"Ball","year":"2015","journal-title":"Urology"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eururo.2014.06.015","article-title":"The relationship between the extent of extraprostatic extension and survival following radical prostatectomy","volume":"67","author":"Jeong","year":"2015","journal-title":"Eur Urol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1464-410X.2009.08957.x","article-title":"The prognostic significance of bladder neck invasion in prostate cancer: is microscopic involvement truly a T4 disease?","volume":"105","author":"Ploussard","year":"2009","journal-title":"BJU Int"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/modpathol.2008.190","article-title":"Microscopic bladder neck involvement by prostate carcinoma in radical prostatectomy specimens is not a significant independent prognostic factor","volume":"22","author":"Zhou","year":"2009","journal-title":"Mod Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"619","DOI":"10.5858\/arpa.2021-0069-OA","article-title":"The clinical impact of pT3a lesions in patients with pT3b prostate cancer undergoing radical prostatectomy: A proposal for a new pT3b subclassification","volume":"146","author":"Numbere","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/his.12199","article-title":"Prognostic significance of histopathological features of extraprostatic extension of prostate cancer","volume":"63","author":"Danneman","year":"2013","journal-title":"Histopathology"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-5347(17)35415-0","article-title":"Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup","volume":"150","author":"Epstein","year":"1993","journal-title":"J Urol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","article-title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial","volume":"376","author":"de Bono","year":"2010","journal-title":"Lancet"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanada","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0046-8177(98)90457-9","article-title":"Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer","volume":"29","author":"Wheeler","year":"1998","journal-title":"Hum Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.pas.0000213359.26003.37","article-title":"Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: a new proposal for the substaging of pT3a prostate cancer","volume":"31","author":"Sung","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2559.2011.03986.x","article-title":"Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy","volume":"59","author":"van Veggel","year":"2011","journal-title":"Histopathology"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1038\/s41598-021-93340-3","article-title":"Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/00365590310014535","article-title":"The role of the pathologist in the evaluation of radical prostatectomy specimens","volume":"37","author":"Ekici","year":"2003","journal-title":"Scand J Urol Nephrol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00428-006-0254-x","article-title":"Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911)","volume":"449","author":"van der Kwast","year":"2006","journal-title":"Virchows Arch"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/PAS.0b013e31817fb3a0","article-title":"Interobserver variability betwee urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens","volume":"32","author":"Evans","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.humpath.2009.05.001","article-title":"A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy","volume":"40","author":"Miyamoto","year":"2009","journal-title":"Hum Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:01:58Z","timestamp":1749416518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001939"}},"subtitle":["A Proposal for a New pT3a Subclassification"],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001939","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,2]]}}}